EMA approval

CHMP opinion, EMA approval, Daiichi Sankyo, Enhertu, Non-Small Cell Lung Cancer, HER2 Mutant NSCLC, DESTINY-Lung02 trial

Enhertu, a Breakthrough Therapy for HER2 Mutant NSCLC, Gets EU Nod

Anika Sharma

Enhertu (trastuzumab deruxtecan) has received a positive recommendation for approval in the European Union (EU) as a standalone treatment for ...

Quizartinib, CHMP opinion, FLT3-ITD Positive AML, EMA approval, acute myeloid leukemia, Daiichi Sankyo

Quizartinib Gets Green Light in EU for Treating Acute Myeloid Leukemia

Anika Sharma

Daiichi Sankyo has received a positive recommendation for the approval of quizartinib in the European Union (EU). This recommendation is ...

Roche, EMA approval, spinal muscular atrophy, European Commission, Evrysdi

Roche’s Evrysdi Illuminates Hope: EC Expands Approval for SMA Infants

Anika Sharma

To provide a brighter future for infants battling spinal muscular atrophy (SMA), Roche has unveiled a momentous development. The European ...

Tecvayli, EMA approval, Multiple myeloma, Johnson & Johnson, Bispecific antibody

Janssen’s Bispecific Antibody Tecvayli Receives European Commission Approval for Reduced Dosing Frequency

Anika Sharma

The Janssen Pharmaceutical Companies of Johnson & Johnson have proudly unveiled a significant advancement in cancer treatment. The European Commission ...